Iannis Aifantis
Affiliations: | Basic Medical Science | New York University, New York, NY, United States |
Area:
Medicine and Surgery, Human Development, Cell BiologyGoogle:
"Iannis Aifantis"Children
Sign in to add trainee| Igor Dolgalev | grad student | (Physics Tree) | |
| Philmo Y. Oh | grad student | 2012 | NYU |
| Linsey Reavie | grad student | 2012 | NYU |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen W, Ma C, Wang H, et al. (2023) A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy. Research Square |
| Glytsou C, Chen X, Zacharioudakis E, et al. (2023) Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discovery |
| Battistello E, Hixon KA, Comstock DE, et al. (2023) Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion. Molecular Cell |
| Lasry A, Nadorp B, Fornerod M, et al. (2023) Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nature Cancer |
| Tan J, Shenker-Tauris N, Rodriguez-Hernaez J, et al. (2023) Cell-type-specific prediction of 3D chromatin organization enables high-throughput in silico genetic screening. Nature Biotechnology |
| Lasry A, Nadorp B, Fornerod M, et al. (2022) An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nature Cancer |
| Kedmi R, Najar TA, Mesa KR, et al. (2022) A RORγt cell instructs gut microbiota-specific T cell differentiation. Nature |
| Yeaton A, Cayanan G, Loghavi S, et al. (2022) The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discovery |
| Carcamo S, Nguyen CB, Grossi E, et al. (2022) Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma. Cell Reports. 39: 110637 |
| Muto T, Guillamot M, Yeung J, et al. (2022) TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. Cell Stem Cell |